Table 1 The number of incident infections ^a , the incidence rate, and incidence rate ratios of individual oral high-risk HPV types in HIV-negative and HIV-infected MSM (H2M study, Amsterdam 2010-2012)

HPV-16

4

4675

0.9

(0.3 - 2.3)

10

2833

3.5

(1.9 - 6.6)

4.1

(1.3 - 13.2)

0.011

HPV-18

2

4750

0.4

(0.1 - 1.7)

8

2901

2.8

(1.4 - 5.5)

6.6

(1.4 - 30.8)

0.007

HPV-31

1

4782

0.2

(0.03 - 1.5)

7

2918

2.4

(1.1 - 5.0)

11.5

(1.4 - 93.2)

0.004

HPV-33

4

4732

0.8

(0.3 - 2.3)

10

2832

3.5

(1.9 - 6.6)

4.2

(1.3 - 13.3)

0.010

HPV-35

1

4727

0.2

(0.03 - 1.5)

4

2973

1.3

(0.5 - 3.6)

6.4

(0.7 - 56.9)

0.058

HPV-39

5

4701

1.1

(0.4 - 2.6)

4

2934

1.4

(0.5 - 3.6)

1.3

(0.3 - 4.8)

0.713

HPV-45

2

4775

0.4

(0.1 - 1.7)

4

2973

1.3

(0.5 - 3.6)

3.2

(0.6 - 17.5)

0.161

HPV-51

3

4693

0.6

(0.2 - 2.0)

10

2908

3.4

(1.9 - 6.4)

5.4

(1.5 - 19.5)

0.005

HPV-52

3

4743

0.6

(0.2 - 2.0)

8

2938

2.7

(1.4 - 5.4)

4.3

(1.1 - 16.2)

0.020

HPV-56

3

4750

0.6

(0.2 - 2.0)

9

2897

3.1

(1.6 - 6.0)

4.9

(1.3 - 18.2)

0.009

HPV-58

0

4798

−

7

2972

2.4

(1.1 - 4.9)

−

HPV-59

1

4770

0.2

(0.03 - 1.5)

4

3001

1.3

(0.5 - 3.6)

6.4

(0.7 - 56.9)

0.058